2 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Melanoma, Experimental: new trials by email Literature Review of Melanoma, Experimental trials Research Report on Melanoma, Experimental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Haploidentical NK Cell Infusion in Malignant Melanoma Haploidentical NK cell - Melanoma | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 12 | 2009-02-01 | 2012-06-08 |
| Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma DMF5 Melanoma Reactive TIL, Cyclophosphamide, Fludarabine - Melanoma, Malignant Melanoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 1 | 2007-08-01 | 2012-10-25 |
| Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma aldesleukin, therapeutic autologous lymphocytes, Cyclophosphamide - Melanoma, Malignant Melanoma | Phase 2 | Completed | National Cancer Institute (NCI) | 158 | 2007-06-01 | 2013-06-03 |
Melanoma (3) · Neoplasms (2) · Skin Neoplasms (1)
Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Experimental (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Neuroectodermal Tumors (3) · Neuroendocrine Tumors (3) · Nevi and Melanomas (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Skin Neoplasms (2) · Neoplasms (1)
Cyclophosphamide (2) · aldesleukin (2) · fludarabine phosphate (2) · Interleukin-2 (1) · Whole-Body Irradiation (1) · fludarabine (1)
National Cancer Institute (NCI) (2) · Seoul National University Hospital (1)
United States (2) · South Korea (1)
Dae Seog Heo, Professor (1) · Deborah E Citrin, M.D. (1) · Steven Rosenberg, M.D. (1)